Search Page

A German finance expert has warned that the country’s federal states could be entering a “dangerous race to the bottom” regarding legislation on transparency in cooperation between industry and higher education. He believes that cooperation agreements should be publicly accessible in order to guarantee academic freedom. The professor of finance and political economy at Aalen University, contested a contract between the University of Mainz and the Boehringer Ingelheim Foundation, the country’s largest pharmaceutical company that also engages in research.

German university heads have welcomed proposals by the Stifterverband – a network of foundations, businesses and individuals supporting the country’s higher education and research – for improved transparency in collaborations between universities and industry. The recommendations, issued in mid-April, stress the “responsibility of universities, as autonomous institutions, to regularly and appropriately inform the public about their collaborative projects with industry”.

The independence of Swiss universities from the corporate world has again been called into question as details of pharmaceutical sponsorship deals were broadcast by Swiss public television, SRF. The programme found evidence that one firm may have manipulated academic research data. SRF research shows financial links between pharma giants and several leading universities. The most damning revelation is that one group demanded to see research every three months and reserved the right to make “acceptable alterations” to results.

A warning by German anti-corruption organisation Transparency International that links between higher education and business are becoming increasingly obscure has sparked an open debate. "We are observing corporate interests increasingly dominating teaching and research to a large extent,” said Director of Transparency International Germany.